September 6, 2022, 5:00 pm - September 6, 2022, 9:00 pm
Limited to 80 registrations. Currently, 74 registrations available.
The large number of emerging antibody-drug conjugates (ADCs) for cancer therapy
has resulted in a significant market ‘boom’, garnering worldwide attention. In
conjuncture with the 2022 World ADC Conference in San Diego, SABPA is
pleased to host its 27th Entrepreneur Symposium together with Biocytogen, inviting a
panel of experts and industry leaders to share experiences and insights about the
latest technologies and trends in the ADC space, including ADC drug design and
development processes as well as business and partnership opportunities. This event
aims to cultivate connections and collaborations among biotech companies and will
be held (mainly) in person.